Citadel Advisors »

Xeris Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6M 680k 2.35
2023-09-30 $601k 323k 1.86
2023-06-30 $980k 374k 2.62
2023-03-31 $279k 171k 1.63
2022-12-31 $369k 277k 1.33
2022-06-30 $557k 361k 1.54
2022-03-31 $1.0M 394k 2.56
2021-12-31 $2.0M 668k 2.93